CDT logo

CDT EQUITY INC

CDTNASDAQ
🏆 #5354 by market capUS Equity
$0.08▲ $0.00 (+3.75%)
🌙 After hours$0.08▼ 7.59%Regular close · extended-hours price shown
🔔
Track CDT
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 3.8%
7d▼ 41.5%
14d▼ 64.9%
30d▼ 95.6%
ytd▼ 100.0%
1y▼ 100.0%
🏦Market Cap
$92,960
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$0.07 – $0.09
52-Week Range
$0.08 – $20,125.00
Volume (shares)
150,328,827
Avg Volume (shares)
—
Shares Outstanding
1.1M
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
—
Last Q Revenue
$750M
P/E Ratio
—
P/S Ratio
—
EPS (TTM)
$-5,400.37
Dividend Yield
—
Dilution (1yr)
+19930.4%
CDT logo

CDT EQUITY INC

CDT
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$37M▲ +138.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$18M▲ +84.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
9K▲ +19930.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$896M▼ −$889M YoY
StockOtter · stockotter.space

About CDT EQUITY INC

Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

GlobeNewsWire·1d ago

CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 27, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company"), today announced that it has entered into an evaluation agreement with Manoira Corporat

GlobeNewsWire·14d ago

CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 14, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company") today notes the announcement from Sarborg Limited regarding intellectual property cover

GlobeNewsWire·29d ago

CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug Discovery

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.

GlobeNewsWire·Sep 25

CDT Equity Inc. Announces Reverse Stock Split

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a 1-for-25 reverse stock split of

GlobeNewsWire·Sep 18

CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.

GlobeNewsWire·Sep 10

CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept.